South Pacific

With a supportive wife, five daughters and eight grandchildren, Tony Sullivan has something to fight for.

An experimental medication that increases height in children with the most common form of dwarfism has raised hope that it can help them lead easier lives. But some say the condition is not a problem in need of a cure.

The federal government has secured a promising vaccine being developed at Oxford University after brokering a deal with a UK-based drug company.

Australia has now signed a deal with drugmaker AstraZeneca to secure its potential COVID-19 vaccine, joining a growing list of countries lining up for supplies of the drug.

The Health Minister has today announced millions of dollars for Pharmac to secure vital medicine amid fears of a global shortage.

Novartis’s Sandoz division will not profit from 15 generic drugs it is making available to developing countries to treat symptoms of COVID-19 for the pandemic’s duration.

Dr. Paul Griffin discusses the COVID-19 vaccine trial underway in Australia and when results are expected after human testing is completed.

More than 14,000 Australian women will be looking for new contraceptive medication after a popular pill experiences widespread shortages.

Coronavirus trial drug Remdesivir has been approved for use in Australia as Victoria registers 216 new cases overnight.

But researchers have warned Australia may be left without supplies if the United States buys up big as it's done with the only drug which is licensed to treat COVID-19.

Australia's PBS has released the list of medicines that are to be included in the October 2020 cycle of price disclosure reductions.

Evidence given to parliamentary committee sparks new calls to develop national capability to manufacture medicines and key supplies.

Today, researchers in Queensland signed a major partnership with a pharmaceutical giant; but it's too soon to say whether the vaccine will work.

Novavax Inc said on Monday it has started the Phase 1 clinical trial of a novel coronavirus vaccine candidate and has enrolled the trial’s first participants, with preliminary results slated for July.

The race for a vaccine is on.